A Review of CYP3A Drug-Drug Interaction Studies: Practical Guidelines for Patients Using Targeted Oral Anticancer Drugs

• Main Authors: Laura Molenaar-Kuijsten (Author), Dorieke E. M. Van Balen (Author), Jos H. Beijnen (Author), Neeltje Steeghs (Author), Alwin D. R. Huitema (Author)
• פורמט: ספר
• יצא לאור: Frontiers Media S.A., 2021-08-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

Many oral anticancer drugs are metabolized by CYP3A. Clinical drug-drug interaction (DDI) studies often only examine the effect of strong CYP3A inhibitors and inducers. The effect of moderate or weak inhibitors or inducers can be examined using physiologically based pharmacokinetic simulations, but...